Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 15/20 | 0.50 |
| ▸ | PRKDC | P78527 | 6/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | NEK2 | P51955 | 1/20 | 0.45 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | LDHB | P07195 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27836947 | 0.87 | ATR (0.54) | ATR | |
| SCHEMBL27912649 | 0.81 | ATR (0.50) | ATRAURKAAURKB | |
| SCHEMBL27836793 | 0.80 | ACVR1 (0.42) | ATRPRKDC | |
| SCHEMBL2581392 | 0.80 | MAPT (0.51) | ATRPRKDCATM | |
| SCHEMBL3459860 | 0.79 | ATR (0.46) | ATRPRKDCNEK2ATM | |
| SCHEMBL14525246 | 0.77 | ATR (0.65) | ATRPRKDCATM | |
| SCHEMBL935340 | 0.75 | AURKA (0.48) | ATRPRKDCAURKAAURKB | |
| SCHEMBL3462566 | 0.75 | ATR (0.66) | ATRPRKDCATM | |
| SCHEMBL28944517 | 0.74 | GRM5 (0.39) | ALOX5 | |
| SCHEMBL27517890 | 0.74 | ATR (0.39) | ATRALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1280289-C | Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists | HOFFMANN LA ROCHE (CH) | 2006-10-18 | — | — | CN | disclosed |
| CN-1494544-A | Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists | - | 2004-05-05 | — | — | CN | disclosed |